FLT3 Mutation Increases Relapse Risk after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia in First or Second Complete Remission: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

被引:0
|
作者
Deol, Abhinav [1 ]
Sengsayadeth, Salyka [2 ]
Jagasia, Madan [2 ]
Ahn, Kwang W. [3 ]
Wang, Hailin [4 ]
Sandmaier, Brenda M. [5 ]
Devine, Steven M. [6 ]
de Lima, Marcos [7 ]
Weisdorf, Daniel J. [8 ]
Saber, Wael [9 ]
机构
[1] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Med Coll Wisconson, CIBMTR, Milwaukee, WI USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[5] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[6] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
[7] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[8] Univ Minnesota, Minneapolis, MN USA
[9] Med Coll Wisconsin, CIBMTR, Milwaukee, WI 53226 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
    Antonio M. Jimenez Jimenez
    Marcos De Lima
    Krishna V. Komanduri
    Trent P. Wang
    Mei-Jie Zhang
    Karen Chen
    Hisham Abdel-Azim
    Muhammad Bilal Abid
    Mahmoud Aljurf
    Hassan Alkhateeb
    Amer Assal
    Ulrike Bacher
    Frédéric Baron
    Minoo Battiwalla
    Amer Beitinjaneh
    Nelli Bejanyan
    Vijaya Raj Bhatt
    Michael Byrne
    Jean-Yves Cahn
    Mitchell Cairo
    Paul Castillo
    Edward Copelan
    Zachariah DeFilipp
    Miguel Angel Diaz Perez
    Mahmoud Elsawy
    Robert Peter Gale
    Biju George
    Michael R. Grunwald
    Gerhard C. Hildebrandt
    William J. Hogan
    Christopher G. Kanakry
    Ankit Kansagra
    Mohamed A. Kharfan-Dabaja
    Nandita Khera
    Maxwell M. Krem
    Aleksandr Lazaryan
    Joseph Maakaron
    Rodrigo Martino
    Joseph McGuirk
    Fotios V. Michelis
    Giuseppe Milone
    Asmita Mishra
    Hemant S. Murthy
    Alberto Mussetti
    Sunita Nathan
    Taiga Nishihori
    Richard F. Olsson
    Neil Palmisiano
    Sagar Patel
    Ayman Saad
    Bone Marrow Transplantation, 2021, 56 : 3068 - 3077
  • [32] Extramedullary Disease at Diagnosis of Acute Myeloid Leukemia Does Not Influence Outcome of Patients Undergoing Allogeneic Hematopoietic Cell Transplant in First Complete Remission
    Michelis, Fotios V.
    Messner, Hans A.
    Alam, Naheed
    Gupta, Vikas
    Kim, Dennis Dong Hwan
    Kuruvilla, John
    Lambie, Anna
    Viswabandya, Auro
    Lipton, Jeffrey H.
    BLOOD, 2015, 126 (23)
  • [33] Allogeneic hematopoietic cell transplantation in elderly non- hodgkin lymphoma patients: A time trends analysis from the center for international blood and marrow transplant research (CIBMTR)
    Hamadani, Mehdi
    Ahn, Kwang Woo
    Litovich, Carlos
    Fenske, Timothy
    Sureda, Anna
    Kharfan-Dabaja, Mohamed
    Shah, Nirav
    BONE MARROW TRANSPLANTATION, 2019, 54 : 109 - 110
  • [34] Pregnancy after Hematopoietic Cell Transplantation: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR)
    Loren, Alison W.
    Chow, Eric
    Jacobsohn, David A.
    Gilleece, Maria
    Halter, Joerg
    Joshi, Sarita
    Wang, Zhiwei
    Sobocinski, Kathleen A.
    Gupta, Vikas
    Hale, Gregory A.
    Marks, David I.
    Stadtmauer, Edward A.
    Apperley, Jane
    Cahn, Jean-Yves
    Schouten, Harry C.
    Lazarus, Hillard M.
    Savani, Bipin N.
    McCarthy, Philip L.
    Jakubowski, Ann A.
    Kamani, Naynesh R.
    Hayes-Lattin, Brandon
    Maziarz, Richard T.
    Warwick, Anne B.
    Sorror, Mohamed L.
    Bolwel, Brian J.
    Socie, Gerard
    Wingard, John R.
    Rizzo, J. Douglas
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : 157 - 166
  • [35] Allogeneic stem cell transplantation (AlloSCT) for the treatment of therapy-related myelodysplastic syndrome (tMDS) and acute myeloid leukemia (tAML): Results from the center for international blood and marrow transplant research (CIBMTR)
    Litzow, Mark
    Perez, Waleska S.
    Tarima, Sergey
    Keating, Armand
    Sierra, Jorge
    Tallman, Martin
    Weisdorf, Daniel
    BLOOD, 2007, 110 (11) : 899A - 899A
  • [36] Provider and Center Characteristics Of US Transplant Centers and Their Association With Survival After Allogeneic Hematopoietic Cell Transplantation (HCT) In Adults: Results From a National Survey Conducted By The Center For International Blood and Marrow Transplant Research (CIBMTR)
    Majhail, Navneet S.
    Payton, Tammy
    Mau, Lih-Wen
    Le Rademacher, Jennifer
    Chitphakdithai, Pintip
    Eckrich, Michael
    Joffe, Steven
    Lee, Stephanie J.
    LeMaistre, Charles F.
    Loberiza, Fausto R., Jr.
    Logan, Brent R.
    Murphy, Elizabeth A.
    Parsons, Susan K.
    Repaczki-Jones, Ramona
    Rizzo, J. Douglas
    Robinett, Pam
    Denzen, Ellen
    BLOOD, 2013, 122 (21)
  • [37] The Role of Hematopoietic Cell Transplantation (HCT) for Burkitt Lymphoma: a Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)
    Gajewski, James L.
    Carreras, Jeanette
    Lazarus, Hillard M.
    Laport, Ginna G.
    Montoto, Silvia
    Maloney, David G.
    Hari, Parameswaran
    BLOOD, 2010, 116 (21) : 990 - 991
  • [38] A Relapse Risk Score to Predict Acute Myeloid Leukemia Relapse After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Based on Pre-Transplant Variables
    Gyurkocza, Boglarka
    Storb, Rainer
    Storer, Barry E.
    Chauncey, Thomas
    Lange, Thoralf
    Laport, Ginna G.
    Langston, Amelia
    Pulsipher, Michael A.
    Bredeson, Christopher
    Maziarz, Richard
    Bruno, Benedetto
    Petersen, Finn
    Maris, Michael
    Agura, Edward
    Yeager, Andrew M.
    Bethge, Wolfgang A.
    Sahebi, Firoozeh
    Appelbaum, Frederick R.
    Maloney, David G.
    Estey, Elihu H.
    Sandmaier, Brenda M.
    BLOOD, 2010, 116 (21) : 1415 - 1416
  • [39] A unique case of durable complete remission after salvage with azacitidine and DLI for high risk flt-3 positive acute myeloid leukemia, following relapse 18 months post allogeneic stem cell transplant
    Horgan, Claire
    Kanellopoulos, Alexandros
    Paneesha, Shankara
    Kishore, Bhuvan
    Lovell, Richard
    Nikolou, Emmanouil
    HEMATOLOGY REPORTS, 2019, 11 (01) : 1 - 3
  • [40] Can allogeneic stem cell hematopoietic transplant with any type of donor be the standard post-remission treatment in intermediate-risk acute myeloid leukemia in first complete remission?
    Cerezo Martin, J. M.
    Bermudez-Rodriguez, A.
    Colorado, M. D. L. M.
    Munoz, P.
    Fernandez-Luis, S.
    Yanez, L.
    Martin, G.
    Fernandez, N.
    Calvo, J. A.
    Insunza Gaminde, A.
    Montes, C.
    Gonzalez, S.
    Batlle, A.
    Briz, M.
    Romon, I.
    Sanchez-Escamilla, M.
    Arroyo, J. L.
    Ocio, E.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 112 - 113